SCHEMBL5500635

SCHEMBL5500635

O=C(CN1CCC(O)CC1)Nc1ccc(Nc2ncc(-c3ccsc3)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
SMYD3 Q9H7B4 1/20 0.40
PORCN Q9H237 1/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
CTSC P53634 1/20 0.40
WNT1 P04628 1/20 0.40
GSK3B P49841 1/20 0.40
DYRK1A Q13627 1/20 0.40
PTK2 Q05397 1/20 0.39
OGA O60502 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
THRB P10828 1/20 0.38
TERT O14746 1/20 0.38
RECQL P46063 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5499974 0.90 KDM4E (0.49) HRH3LMNAHTTKDM4EALDH1A1
SCHEMBL5496779 0.89 KDM4E (0.51) HRH3KDM4EALDH1A1THRB
SCHEMBL5496170 0.88 MGLL (0.48) SMN1; SMN2PORCNLMNACTSCGSK3B
SCHEMBL5494719 0.87 ATM (0.52) HRH3SMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL5530225 0.82 PARP1 (0.49) HRH3SMN1; SMN2CTSCKDM4EALDH1A1
SCHEMBL5501185 0.81 HRH3 (0.38) HRH3SMN1; SMN2PORCNHTTCTSC
SCHEMBL5503212 0.80 POLB (0.57) SMN1; SMN2CTSCKDM4EALDH1A1TERT
SCHEMBL5496471 0.79 CTSC (0.49) SMN1; SMN2PORCNHTTCTSCKDM4E
SCHEMBL5501739 0.78 ALDH1A1 (0.53) SMN1; SMN2LMNAHTTALDH1A1NPSR1
SCHEMBL5503055 0.77 POLB (0.45) SMN1; SMN2LMNACTSCKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US claimed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP claimed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO claimed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 HRH3 1572/4885SMN1; SMN2 3601/4885SMYD3 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.